Actemra Tocilizumab 80 mg/4 ml, 200 mg/10 ml, 400mg/20 ml

DESCRIPTION

Actemra is a prescription cancer drug used to treat moderate to severe rheumatoid  arthritis in adults. It is also used to treat systemic juvenile idiopathic arthritis (or “Still disease”) in children who are at least 2 years old.To buy Actemra 80 mg/4 ml, 200 mg/10 ml, 400mg/20 ml or to know its price contact 3S Corporation.

Manufacturer: Genentech, Inc.

ADDITIONAL INFORMATION

Strengthsavailable : 80 mg/4 ml, 200 mg/10 ml, 400mg/20 ml

Form :Injection

Dosage : The recommended dosage of ACTEMRA for adult patients given as a 60-minute single intravenous drip infusion is 4 mg per kg every 4 weeks followed by an increase to 8 mg per kg every 4 weeks based on clinical response.

The recommended dosage of ACTEMRA for PJIA patients given once every 4 weeks as a 60-minute single intravenous drip infusion is- 10 mg per kg (patients less than 30 kg weight), 8 mg per kg ( patients at or above 30 kg weight ).

Storage :Store at 2° to 8°C

Is the medicine US FDA  approved :Yes

Date of Approval :January 8, 2010

SIDE EFFECTS

Common side effects are Burning, dry, or itching eyes, constipation, discharge, excessive , tearing, redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid, skin rash, encrusted, scaly and oozing, swelling or inflammation of the mouth, warmth on the skin.

PACK SIZE

Pack of 1 vial

Reviews

There are no reviews yet.

Be the first to review “Actemra Tocilizumab 80 mg/4 ml, 200 mg/10 ml, 400mg/20 ml”

Your email address will not be published. Required fields are marked *